-
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
25 Sep 2025 05:15 GMT
… US Food and Drug Administration (FDA) for cUTI and … of effective oral antibiotic treatment options.[2] Currently, … to discovering, developing and commercializing innovative drugs to meet … similar expressions concerning Basilea Pharmaceutica Ltd, Allschwil and …
-
SeaStar Medical Stock Jumps On Safety Board Backing For Kidney Trial; Retail Eyes Another Run Despite After-Hours Plunge
25 Sep 2025 06:12 GMT
… recommended continuing its pivotal trial of a kidney failure therapy.
However, … in adults with acute kidney injury requiring continuous renal replacement … events tied to the treatment. It also flagged a … by the FDA for life-threatening acute kidney injury in …
-
Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 months
25 Sep 2025 03:51 GMT
… (₹500 crore). Sudeep Pharma, which submitted draft papers … 1,085 crore and Corona Remedies (₹800 crore).
Agencies
Fertility … ₹500 crore) and Gujarat Kidney and Superspeciality Hospital (₹128 … drugs, etc," he said.
Further, Bahl said, Indian pharma …
-
Stem cell treatment could help millions of people with end-stage kidney disease
25 Sep 2025 02:15 GMT
… end-stage kidney disease that requires hemodialysis, a treatment in … a phase I clinical trial. Eleven participants were injected … more information through larger clinical trials.
"This approach … validated in larger clinical trials," says Dr. Misra …
-
Stem cell therapy at Mayo Clinic offers new kidney treatment options
25 Sep 2025 02:17 GMT
… with end-stage kidney disease.
Hemodialysis is a treatment in which a … needing a kidney transplant.
In a phase I clinical trial, 21 … , paving the way for personalized treatments.
"This approach has … guidelines through larger clinical trials.
-
Kidney patients at higher risk of severe COVID-19 infection
24 Sep 2025 23:51 GMT
… booster vaccines especially in kidney transplant patients. However, … kidney transplant. These patients are at greater risk of developing … reduced the risk of kidney patients becoming hospitalized, …
In patients receiving dialysis treatment, 2–3 vaccine doses …
-
People with Medicare Will Face Higher Costs for Some Orphan Drugs Due to Changes in the New Tax and Budget Law
24 Sep 2025 23:32 GMT
… on orphan drug research and development if drugs approved to … s orphan drug exclusion supported by the pharmaceutical industry in … non-orphan indications for kidney cancer in April 2018 … liability for these expensive medications might continue to represent …
-
Sandoz launches affordable iron sucrose injection for treatment of iron deficiency anemia in patients with chronic kidney disease in US
24 Sep 2025 20:39 GMT
… iron sucrose injection was developed in partnership with … treatment of iron deficiency anemia (IDA) in patients with chronic kidney … clinical trial. The American Journal of Kidney Diseases: … S. Food and Drug Administration. FDA Approved Indications for …
-
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
24 Sep 2025 20:22 GMT
… company focused on transforming treatments for critically ill … a randomIZEd clinical trial in Acute Kidney Injury) is an … and Drug Administration (FDA). QUELIMMUNE is the only FDA approved product … are unable to successfully develop and commercialize its …
-
Wegovy vs. Ozempic: Which Is the Better Weight Loss Drug?
24 Sep 2025 20:29 GMT
… check prices at different pharmacies and online to find … also look at your kidney health and cardiovascular risks, … , insurance coverage, and drug shortages or availability.
How … conditions, medications, and your current response to treatment.
Alternatives to …